New principal investigator for Sinopharm clinical trial appointed

In order to continue phase 3 studies with the Sinopharm vaccine in Peru, the Universidad Peruana Cayetano Heredia (UPCH) reported that they appointed Dr. Coralith García as the principal investigator of the clinical trial. The researcher is the replacement of the suspended doctor Germán Málaga, who participated in the Vacunagate scandal.


See Also:  UAE puts third dose of Chinese vaccine in cases that do not get antibodies | WORLD

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.